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S U M M A R Y
Background: To date, infections have usually been associated with elevations of the mean platelet
volume. We correlated infection with respiratory syncytial virus (RSV) with changes in mean platelet
volume (MPV).
Methods: A consecutive series of patients with positive and negative rapid RSV assays and viral cultures,
as well as children under 10 years of age with bronchoscopy for pneumonia or airway obstruction, were
compared.
Results: The MPV was signiﬁcantly lower in patients with positive versus negative rapid RSV assays
(9.7  0.8 vs. 10.5  0.9 ﬂ, p < 0.001), as well as viral cultures (9.9  1.0 vs. 10.5  1.0 ﬂ, p < 0.001). Children
with RSV undergoing bronchoscopy (n = 7) also had signiﬁcantly lower MPV than children without RSV
(n = 79) (8.8  1.0 vs. 10.2  1.1 ﬂ, p < 0.004). An MPV <8.9 ﬂ had a sensitivity of 71% and speciﬁcity of 49%
for RSV in children undergoing bronchoscopy.
Conclusions: We conclude that infection with RSV is associated with decreased MPV and this may be
clinically useful in children undergoing bronchoscopy.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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The mean platelet volume (MPV) is a laboratory value that is
deﬁned as the mean volume of a large number of platelets as
measured on automated hematology machines. MPV is associated
with many factors including platelet age (younger platelets are
larger), and is measured to help evaluate abnormalities in platelet
function or number. MPV has also been associated with a wide
variety of different medical and non-medical conditions. Elevations
of the MPV have been described in smokers,1 high elevation living,2
diabetes,3 obese patients,4,5 and wine drinkers.6 In addition,
elevated MPVs are seen in patients who have thrombocytope-
nia,7–9 hypothyroidism,10 congestive heart failure,11 right ventricu-
lar enlargement,12 acute pulmonary embolism,12 stroke,13 acute
myocardial infarction,14 unstable angina,15 and hypoxic chronic
obstructive pulmonary disease.16 Higher MPVs are associated with
autoimmunity in general,17 as well as psoriasis,18 Raynaud’s
disease,19 rheumatoid arthritis, and ankylosing spondylitis, and
this correlates with the degree of activity as well as lack of
treatment.20,21
In contrast, decreases in MPV have most commonly been
associated with anemia22 and chronic renal failure,23 but have also* Corresponding author. Tel.: +1 786 596 6525; fax: +1 786 596 5986.
E-mail address: andrewr@baptisthealth.net (A.A. Renshaw).
1201-9712/$36.00 – see front matter  2013 International Society for Infectious Disea
http://dx.doi.org/10.1016/j.ijid.2013.01.012been described in patients with vascular malformations,24 as well
as acute appendicitis,25 acute pancreatitis,26 ulcerative colitis, and
Crohn’s disease (which also correlates with the severity of the
activity and is reversed with therapy).27–30
Only a few studies have examined the effects of infection on
MPV. In a canine model, endotoxemia was associated with an
increase in MPV,31 and in humans, tuberculosis infection has been
associated with a higher MPV which decreases with therapy.32
Increased MPVs are also seen with lower platelet counts in patients
with Crimean-Congo hemorrhagic fever.33 Decreases in MPV have
also been associated with some infections, including sepsis,34
hookworm,35 and Trichinella.36 Recently, we noticed that some
patients with infection with respiratory syncytial virus (RSV) had
relatively low MPVs. To investigate this, we examined MPVs in a
consecutive series of patients in a variety of settings.
2. Methods
This study was approved by the Institutional Review Board. A
consecutive series of patients with positive and negative rapid RSV
assays and viral cultures from respiratory specimens, as well as
children under 10 years of age with bronchoscopy for pneumonia
or airway obstruction, were compared. Searches began in January
of 2012 and were conducted retrospectively until either 100
patients were obtained or no more cases were identiﬁed in theses. Published by Elsevier Ltd. All rights reserved.
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logic diseases were excluded.
MPV was assessed on Sysmex 2100 hematology instrumenta-
tion. Reference ranges were 7.7–13.2 ﬂ. The rapid RSV assay was
performed using the BinaxNow RSV by Inverness Medical.
Specimens for viral culture were submitted fresh in sterile
containers using viral transport medium VTM-M4 and inoculated
onto shell vials of MRC5-CV1 (H&V), Super E-Mix, and R-Mix Too
monolayer cultures. Cytopathic effect (CPE) conﬁrmation for RSV
and blind staining for RSV were performed at 48 h, 3 days, and 5
days of culture using an indirect ﬂuorescent antibody respiratory
stain (Quidel Corp., Santa Clara, CA, USA). Patients who were
positive with the rapid test did not have cultures performed.
Cultures were done on patients with either no rapid RSV test or in
whom the rapid test was negative.
The statistical analysis was performed using a two-tailed
Student’s t-test and a signiﬁcance level of 0.05%.
3. Results
A consecutive series of 100 patients with ordered complete
blood counts were used as a control group to verify our normal
range. These patients had a mean MPV of 10.8  0.9 ﬂ.
MPV was compared in patients with rapid RSV tests (58
patients) and viral cultures (100 patients). These patients did not
have an underlying hematologic disease and were both children
and adults (mean age 38 years, range 16–91 years, 112 patients
aged <18 years). They included 69 males and 89 females.
The MPV was signiﬁcantly lower in patients with positive
versus negative rapid RSV assays (9.7  0.8 vs. 10.5  0.9 ﬂ,
p < 0.001, n = 100 each), as well as viral cultures (9.9  1.0 vs.
10.5  1.0 ﬂ, p < 0.001). Nevertheless, there was signiﬁcant overlap
between these two groups. Platelet counts were not signiﬁcantly
different between any of these four groups (342  121 vs.
327  171  109/l, p = 0.47, and 350  144 vs. 338  158  109/l,
p = 0.63, respectively). Hemoglobin was not signiﬁcantly different
between these four groups (11.6  1.4 vs. 11.9  1.2 g/dl, p = 0.11,
and 12.1  1.8 vs. 11.7  1.0 g/dl, p = 0.07).
Children with RSV undergoing bronchoscopy (n = 7) also had
signiﬁcantly lower MPV than children without RSV (n = 79)
(8.8  1.0 vs. 10.2  1.1 ﬂ, p < 0.004). An MPV <8.9 ﬂ had a
sensitivity of 71% and speciﬁcity of 49% for RSV in children
undergoing bronchoscopy.
4. Discussion
We were motivated to do this study by an incidental ﬁnding of a
very low MPV in a child with RSV. Our results support the idea that
infection with RSV is associated with a decrease in MPV regardless
of whether the infection is detected by rapid assay or culture.
While signiﬁcant, this difference is unlikely to be large enough to
be useful in most clinical settings. However, in children who are
undergoing bronchoscopy for presumptive pneumonia or airway
obstruction, an MPV <8.9 ﬂ was relatively sensitive and speciﬁc for
infection with RSV. This change was not due to anemia, since there
was no signiﬁcant difference in hemoglobin between the RSV-
positive and RSV-negative patients.
Measuring MPV can be problematic. MPV increases with
prolonged storage in ethylenediaminetetraacetic acid (EDTA)37
and there is variation in the measurement between analyzers,
although there is substantial work to standardize this.38 In this
study, all measurements were made at the same hospital on the
same analyzer, and specimens were received and processed in the
usual fashion without substantial delays in measurement.
Changes in MPV are quite common in a variety of normal and
pathologic conditions. Autoimmune and cardiac conditions andmost infections measured to date tend to lead to an elevated
MPV. This elevated MPV is often thought to be due to an increase
in young platelets that are larger than more mature platelets. In
contrast, vascular malformations and inﬂammatory conditions
involving the bowel are often associated with a decrease in MPV.
The mechanism of action of this change is not fully understood.
Whether fragmentation of the platelets is involved is not known.
Nevertheless, the most common cause of a decreased MPV is
anemia, which is not known to cause platelet fragmentation. The
speciﬁc mechanism of action of RSV on MPV is not known. As
part of this study we examined the MPV of patients with other
types of viral infections and could not demonstrate a consistent
relationship between these other viral infections and changes in
MPV. Thus we suspect that the effect of RSV on MPV is speciﬁc to
this virus, at least among the commonly detected viruses in our
hospital.
There are several limitations to this study. We chose to study
MPV at the time of specimen collection for RSV. It is possible
that the MPV changed over the course of the admission and the
illness, and if so, we were not able to document this change.
Similarly, our assessments of hemoglobin and platelet count
were also performed at the time of specimen collection. It is
possible that these variables also could have changed over the
course of the illness. In addition, the timing of the specimen
collection likely varied between the patients course of illness.
We were not able to control for this variable. Finally,
interventions by the medical staff to treat the illness were
not controlled for in this study.
In conclusion, we have shown that infection with RSV as
determined by both rapid testing and culture is associated with
decreased MPV. This may be particularly useful clinically in
children undergoing bronchoscopy.
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